Sequencing and analyzing the t(1;7) reciprocal translocation breakpoints associated with a case of childhood-onset schizophrenia/autistic disorder.

Scientists mapped the exact spots where chromosome 1 and chromosome 7 break and rejoin in one boy with both autism and childhood-onset schizophrenia. They used lab tools to read the DNA letters around the break.

The boy carried a balanced translocation. That means no DNA was lost or gained—just moved. The team checked if any known gene sat right on the break.

The break fell between genes. No well-known autism or schizophrenia gene was cut in half.

The finding still pins down a spot on the genome that future researchers can watch. It adds one more dot to the genetic map of autism.

Cramm et al. (2009) did the same kind of single-case mapping. They found a large duplication on chromosome 8p21 in a teen with autism and self-injury. Both studies hunt rare DNA changes, but the 8p21 paper points to two new gene suspects while R et al. came up empty.

Gallagher et al. (2003) also mapped one patient—a boy with a chromosome 2 deletion. Like R et al., they could not name a disrupted gene. Together these papers show that rare breaks often land in 'desert' regions, so the clinical payoff is still downstream.

Shields et al. (2013) widened the lens. They tracked the well-known 15q11-q13 duplication across many kids. Their case-series design showed a clear EEG marker, something a single-case report like R et al. cannot do. The message: big cohort studies turn genetic clues into tools you might actually use.

This paper is a brick in the foundation, not a toolbox. It tells you that not every chromosomal oddity hits a gene you can name. When you read a genetics consult that says 'variant of unknown significance,' remember studies like this—mapping moves science forward even when the answer is 'no gene found.' Keep focusing on behavior skills and data-based interventions; the genome part is still for the lab, not your session plan.